CClinicalTrials.gg
CompletedNCT02916342Updated Nov 4, 2019

Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks

A Phase 4 interventional study of Interscalene brachial plexus block and Supraclavicular-axillary nerve blocks in Analgesia and Diaphragm, sponsored by Centre Hospitalier Universitaire Vaudois. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-04.

Sponsored by Centre Hospitalier Universitaire Vaudois · Phase 4, Interventional, and Other

Phase
Phase 4
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The interscalene block provides effective analgesia after shoulder surgery. It consists of injecting local anaesthetic within the brachial plexus, in the interscalene groove, between the anterior and middle scalene muscles. Unfortunately, this technique is associated with respiratory complications such as hemidiaphragmatic paresis due to the spread of the local anaesthetic towards the phrenic nerve that lies close to the brachial plexus, with an incidence up to 100%. The diaphragmatic paresis may be a serious side-effect, especially in patients suffering from a reduced respiratory function such as chronic obstructive pulmonary disease; this entity may even represent a contraindication to the performance of the block.

The shoulder is mainly innervated by the suprascapular and axillary nerves, both of them coming from C5 and C6 branches of the brachial plexus block. Recently, several authors have successfully identified and block these two nerves under ultrasound guidance. Only one randomised controlled trial compared interscalene block with a combination of suprascapular and axillary nerve blocks, and showed inconclusive results probably due to the absence of ultrasound guidance; indeed, analgesia was equivalent at the sixth postoperative hour, while patients with an interscalene block had reduced pain scores in the recovery room. Besides, the authors did not investigate the impact on the respiratory function.

In that randomised controlled trial, the investigators would like to compare the analgesic efficacy and the respiratory outcomes between the interscalene block and the combined suprascapular-axillary nerve blocks.

02

Conditions studied

  • Analgesia
  • Diaphragm
03

In context

Lead sponsor

Centre Hospitalier Universitaire Vaudois is the lead sponsor of 203 studies on the registry; 47 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ASA physical status I-III;
  • 18-85 years of age, inclusive;
  • surgery less than 3 hours.

Exclusion criteria

Exclusion Criteria:

  • indication for catheter insertion;
  • contraindications to brachial plexus block (e.g., allergy to local anaesthetics, malignancy or infection in the area);
  • existing neurological deficit in the area to be blocked;
  • pregnancy;
  • history of neck surgery or radiotherapy;
  • severe respiratory disease;
  • chest deformity;
  • inability to understand the informed consent and demands of the study;
  • patient refusal.
05

Study design

Phase
Phase 4
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Interscalene brachial plexus block

    An ultrasound-guided interscalene brachial plexus block will be performed prior to surgery.

    Procedure: Interscalene brachial plexus block

  • Experimental
    Supraclavicular-axillary nerve blocks

    A dual supraclavicular-axillary nerve blocks will be performed prior to surgery.

    Procedure: Supraclavicular-axillary nerve blocks

Interventions

  • ProcedureInterscalene brachial plexus block

    Patients will receive an ultrasound-guided interscalene brachial plexus block before general anaesthesia.

  • ProcedureSupraclavicular-axillary nerve blocks

    Patients will receive ultrasound-guided supraclavicular and axillary nerve blocks before general anaesthesia.

06

What researchers measure

Primary outcomes

  1. Presence of hemidiaphragmatic paresis (yes/no)

    Time frame: 30 minutes after the injection

Secondary outcomes

  1. Forced expiratory volume in 1 second (liters)

    Time frame: 30 minutes after the injection

  2. Peak expiratory flow (liters/minute)

    Time frame: 30 minutes after the injection

  3. Forced vital capacity (liters)

    Time frame: 30 minutes after the injection

  4. Pain scores in phase 1 recovery (visual analogue scale, 0-10)

    Visual analogue scale, 0-10

    Time frame: 2 hours after surgery

  5. Pain scores at 24 hours postoperatively (visual analogue scale, 0-10)

    Visual analogue scale, 0-10

    Time frame: Postoperative day 1

  6. Intravenous morphine consumption in phase 1 recovery (mg)

    Time frame: 2 hours postoperatively

  7. Oxycodone consumption at 24 hours postoperatively (mg)

    Time frame: Postoperative day 1

07

Study locations

1 site
  • Lausanne University Hospital
    Lausanne, Vaud 1011, Switzerland
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 4, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02916342
Lead sponsor
Centre Hospitalier Universitaire Vaudois
Responsible party
Eric Albrecht (PD Dr, Centre Hospitalier Universitaire Vaudois) — Principal investigator
First posted
Sep 27, 2016
Start date
Sep 2016
Primary completion
Apr 2019
Completion
Apr 2019
Last update
Nov 4, 2019

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion